Sulfamethoxazole/trimethoprim resistance overcall by VITEK® 2 and BD Phoenix™ in community-associated MRSA and MSSA

J Antimicrob Chemother. 2019 Dec 1;74(12):3639-3641. doi: 10.1093/jac/dkz361.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Australia
  • Clinical Laboratory Techniques
  • Community-Acquired Infections / microbiology*
  • Drug Resistance, Bacterial / genetics*
  • Humans
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Microbial Sensitivity Tests
  • Population Groups
  • Reagent Kits, Diagnostic
  • Reproducibility of Results
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects
  • Trimethoprim Resistance / genetics*
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Reagent Kits, Diagnostic
  • Trimethoprim, Sulfamethoxazole Drug Combination